ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999